News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,496 Results
Type
Article (14119)
Company Profile (293)
Press Release (251084)
Section
Business (80310)
Career Advice (153)
Deals (13302)
Drug Delivery (32)
Drug Development (50585)
Employer Resources (32)
FDA (5723)
Job Trends (5253)
News (145647)
Policy (10229)
Tag
Academia (930)
Alliances (21662)
Alzheimer's disease (740)
Approvals (5687)
Artificial intelligence (61)
Bankruptcy (97)
Best Places to Work (4609)
Biotechnology (242)
Breast cancer (59)
Cancer (623)
Cardiovascular disease (52)
Career advice (135)
CAR-T (49)
Cell therapy (160)
Clinical research (39869)
Collaboration (210)
Compensation (86)
COVID-19 (1025)
C-suite (61)
Cystic fibrosis (61)
Data (670)
Diabetes (66)
Diagnostics (1255)
Earnings (29068)
Events (49821)
Executive appointments (157)
FDA (5977)
Funding (215)
Gene editing (52)
Gene therapy (130)
GLP-1 (296)
Government (1129)
Healthcare (6791)
Infectious disease (1060)
Inflammatory bowel disease (89)
IPO (7215)
Job creations (873)
Job search strategy (130)
Layoffs (183)
Legal (1432)
Lung cancer (104)
Manufacturing (70)
Medical device (2659)
Medtech (2660)
Mergers & acquisitions (6174)
Metabolic disorders (211)
Neuroscience (924)
NextGen Class of 2024 (2113)
Non-profit (974)
Northern California (840)
Obesity (122)
Opinion (90)
Parkinson's disease (55)
Patents (47)
People (25228)
Pharmaceutical (48)
Phase I (14008)
Phase II (18520)
Phase III (11796)
Pipeline (217)
Postmarket research (862)
Preclinical (5928)
Radiopharmaceuticals (205)
Rare diseases (145)
Real estate (1437)
Regulatory (8266)
Research institute (957)
Southern California (777)
Startups (1973)
United States (7041)
Vaccines (164)
Weight loss (76)
Date
Today (149)
Last 7 days (636)
Last 30 days (2002)
Last 365 days (20817)
2024 (18325)
2023 (22726)
2022 (27172)
2021 (28293)
2020 (23834)
2019 (17049)
2018 (12353)
2017 (13978)
2016 (12180)
2015 (14683)
2014 (10602)
2013 (7659)
2012 (7784)
2011 (7852)
2010 (7607)
Location
Africa (153)
Asia (17136)
Australia (2870)
California (1909)
Canada (666)
China (142)
Colorado (75)
Connecticut (78)
Europe (36676)
Florida (201)
Georgia (55)
Illinois (122)
Indiana (57)
Kansas (55)
Maryland (284)
Massachusetts (1599)
Michigan (49)
Minnesota (87)
New Jersey (514)
New York (569)
North Carolina (386)
Northern California (840)
Ohio (74)
Pennsylvania (398)
South America (216)
Southern California (777)
Texas (199)
Washington State (205)
265,496 Results for "summit therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lung cancer
Despite Win Over Keytruda, Summit’s NSCLC Bispecific Still Has Something to Prove
Summit Therapeutics’ ivonescimab has the potential to challenge Merck’s blockbuster checkpoint inhibitor in non-small cell lung cancer, but experts stress the need for diverse and overall survival data.
September 18, 2024
·
5 min read
·
Kate Goodwin
Business
Summit Therapeutics Appoints Jeff Huber, Transformational Google and GRAIL Executive, to its Board of Directors
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that Jeff Huber has been appointed to its Board of Directors, effective immediately.
June 27, 2024
·
8 min read
Biotech Bay
Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper) today announced today announced that its management will present at the Oppenheimer Novel Targets in Immunology Summit, to be held on Monday, June 24, 2024, in New York City.
June 17, 2024
·
4 min read
Press Releases
Foghorn Therapeutics to Participate in the BMO Oncology Summit
October 1, 2024
·
1 min read
Lung cancer
Summit Declares NSCLC Victory Over Keytruda, Analysts Advise Caution With China-Only Data
In advanced non-small cell lung cancer, Summit Therapeutics’ ivonescimab appears to be 49% more effective at reducing the risk of disease progression or death versus Merck’s Keytruda in a late-stage study. However, analysts contend the caveat is that the trial was conducted in an entirely Chinese patient population.
September 9, 2024
·
2 min read
·
Tristan Manalac
News
Aprea Therapeutics to Present at Maxim 2024 Healthcare Virtual Summit
October 14, 2024
·
4 min read
Press Releases
Summit Therapeutics Raises $235 Million
September 12, 2024
·
9 min read
Deals
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced the grant of inducement awards of options to purchase a collective total of up to 200,000 shares of common stock. An award was made to one new employee of the Company.
May 30, 2024
·
4 min read
News
Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit
October 8, 2024
·
1 min read
BioForest
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
Aptevo Therapeutics Inc. today announced a presentation at The Essential Protein & Antibody Engineering Summit (PEGS) conference in Boston MA.
May 14, 2024
·
8 min read
1 of 26,550
Next
